PR Newswire - IASO Biotechnology Announces Acquisition of Singap...
NANJING, China and SINGAPORE, Aug. 14, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio) today announced the completion of its acquisition of MediSix Therapeutics ("MediSix"), a Singapore-based immu...
Read More


ภาษาไทย
English